Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 122 articles: HTML format

Single Articles

September 2022
1. PEREIRA MQ, David C, Almeida AG, Brito D, et al
   Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
   Int J Cardiol. 2022;362:76-82.
   PubMed     Abstract available
   
   
   July 2022
2. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
   Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
   Int J Cardiol. 2022;359:20-27.
   PubMed     Abstract available
   
   
   
3. GOEL A, Singhal M, Malik AH, Gupta R, et al
   Patent foramen ovale closure for recurrent stroke prevention: Recent evidence towards individualized decision-making.
   Int J Cardiol. 2022;358:25.
   PubMed    
   
   
   June 2022
4. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
   Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
   Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
   PubMed     Abstract available
   
   
   May 2022
5. KE Y, Wang J, Wang W, Guo S, et al
   Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
   Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
   PubMed     Abstract available
   
   
   
6. PRACON R, Zielinski K, Bangalore S, Konka M, et al
   Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
   Int J Cardiol. 2022;354:17-21.
   PubMed     Abstract available
   
   
   April 2022
7. DALE Z, Chandrashekar P, Al-Rashdan L, Gill S, et al
   Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.
   Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00559.
   PubMed     Abstract available
   
   
   
8. XUE W, Tian Y, Jing L, Li R, et al
   Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population.
   Int J Cardiol. 2022;353:103-108.
   PubMed     Abstract available
   
   
   
9. JOLOBE OMP
   Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
   Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
   PubMed    
   
   
   
10. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    PubMed    
    
    
    
11. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    PubMed     Abstract available
    
    
    March 2022
12. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    PubMed     Abstract available
    
    
    
13. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    PubMed     Abstract available
    
    
    February 2022
14. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    PubMed     Abstract available
    
    
    
15. GONZALEZ PEREZ A, Balabanova Y, Saez ME, Brobert G, et al
    Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom.
    Int J Cardiol. 2022 Feb 2. pii: S0167-5273(22)00190.
    PubMed     Abstract available
    
    
    
16. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    PubMed     Abstract available
    
    
    January 2022
17. LI X, Jia Z, Yan Y
    Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00186.
    PubMed     Abstract available
    
    
    
18. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    PubMed     Abstract available
    
    
    December 2021
19. HUANG CK, Wang JC, Chung CH, Chen SJ, et al
    The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study.
    Int J Cardiol. 2021 Dec 23. pii: S0167-5273(21)02038.
    PubMed     Abstract available
    
    
    
20. D'ANCONA G, Arslan F, Safak E, Weber D, et al
    Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    Int J Cardiol. 2021 Dec 17. pii: S0167-5273(21)02019.
    PubMed     Abstract available
    
    
    
21. DI LULLO L, Lavalle C, Magnocavallo M, Mariani MV, et al
    New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.
    Int J Cardiol. 2021;345:90-97.
    PubMed     Abstract available
    
    
    
22. BONAVENTURA A
    Assisted reproductive technologies and stroke: Risk factor, predictor of poor outcome, or both?
    Int J Cardiol. 2021;344:220-221.
    PubMed    
    
    
    November 2021
23. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    PubMed     Abstract available
    
    
    
24. RAHMAN MU, Amritphale A, Kumar S, Trice C, et al
    Assessment of independent clinical predictors of early readmission after percutaneous endoluminal left atrial appendage closure with the Watchman device using National Readmission Database.
    Int J Cardiol. 2021;343:21-26.
    PubMed     Abstract available
    
    
    
25. BONETTI NR, Meister TA, Soria R, Akhmedov A, et al
    In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
    Int J Cardiol. 2021;343:92-101.
    PubMed     Abstract available
    
    
    
26. MARSTON XL, Wang R, Yeh YC, Zimmermann L, et al
    Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study.
    Int J Cardiol. 2021 Nov 12. pii: S0167-5273(21)01776.
    PubMed     Abstract available
    
    
    
27. ZHENG X, Wang F, Zhang J, Cui X, et al
    Using machine learning to predict atrial fibrillation diagnosed after ischemic stroke.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01773.
    PubMed     Abstract available
    
    
    
28. SILVERIO A, Di Maio M, Buccheri S, De Luca G, et al
    Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01784.
    PubMed     Abstract available
    
    
    September 2021
29. RADINOVIC A, Falasconi G, Marzi A, D'Angelo G, et al
    Long-term outcome of left atrial appendage occlusion with multiple devices.
    Int J Cardiol. 2021 Sep 29. pii: S0167-5273(21)01492.
    PubMed     Abstract available
    
    
    
30. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    PubMed    
    
    
    
31. SHANG L, Sun H, Tang B
    Screening for atrial fibrillation in older populations: Outcome is more important than detection.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01486.
    PubMed    
    
    
    
32. SPARROW RT, Sanjoy SS, Lindman BR, Tang GHL, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair.
    Int J Cardiol. 2021 Sep 20. pii: S0167-5273(21)01478.
    PubMed     Abstract available
    
    
    
33. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    PubMed     Abstract available
    
    
    
34. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    PubMed     Abstract available
    
    
    
35. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    PubMed     Abstract available
    
    
    August 2021
36. WANG W, Liu Y, Liu J, Yin P, et al
    Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system.
    Int J Cardiol. 2021 Aug 25. pii: S0167-5273(21)01300.
    PubMed     Abstract available
    
    
    
37. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available
    
    
    
38. SEN J, Tonkin A, Varigos J, Fonguh S, et al
    Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
    Int J Cardiol. 2021;337:9-15.
    PubMed     Abstract available
    
    
    
39. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    PubMed    
    
    
    July 2021
40. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    PubMed    
    
    
    
41. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available
    
    
    
42. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    PubMed     Abstract available
    
    
    
43. NEDIOS S
    Screening for atrial fibrillation: Does cardiovascular disease reduce the probability of detection?
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01097.
    PubMed    
    
    
    
44. VEDOVATI MC, Tratar G, Mavri A, Mazzetti M, et al
    Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01099.
    PubMed     Abstract available
    
    
    
45. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    PubMed     Abstract available
    
    
    June 2021
46. VAN DER MATEN G, Dijkstra S, Meijs MFL, von Birgelen C, et al
    Cardiac imaging in ischemic stroke or transient ischemic attack of undetermined cause: Systematic review & meta-analysis.
    Int J Cardiol. 2021 Jun 28. pii: S0167-5273(21)01083.
    PubMed     Abstract available
    
    
    
47. FAROUX L, Cruz-Gonzalez I, Arzamendi D, Freixa X, et al
    Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Int J Cardiol. 2021;333:77-82.
    PubMed     Abstract available
    
    
    May 2021
48. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    PubMed     Abstract available
    
    
    
49. MINHAS A, Shade JK, Cho SM, Michos ED, et al
    The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00823.
    PubMed     Abstract available
    
    
    
50. MANNINA C, Jin Z, Matsumoto K, Ito K, et al
    Frequency of cardiac arrhythmias in older adults: Findings from the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00818.
    PubMed     Abstract available
    
    
    
51. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    PubMed    
    
    
    
52. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    PubMed    
    
    
    April 2021
53. LANGER A, Healey JS, Quinn FR, Honos G, et al
    Detection of atrial fibrillation in asymptomatic at-risk individuals.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00737.
    PubMed     Abstract available
    
    
    
54. ELGENDY IY, Mansoor H, Pepine CJ
    Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
    Int J Cardiol. 2021;328:218-219.
    PubMed    
    
    
    
55. MISHRA SR, Waller M, Chung HF, Mishra GD, et al
    Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: Insights from a 20-year prospective study.
    Int J Cardiol. 2021;328:206-214.
    PubMed     Abstract available
    
    
    March 2021
56. GAWALKO M, Dobrev D
    Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00479.
    PubMed    
    
    
    
57. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    PubMed    
    
    
    
58. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    PubMed     Abstract available
    
    
    
59. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    PubMed     Abstract available
    
    
    February 2021
60. GIEHM-REESE M, Johansen MN, Kronborg MB, Jensen HK, et al
    Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Int J Cardiol. 2021 Feb 27. pii: S0167-5273(21)00366.
    PubMed     Abstract available
    
    
    
61. KOZIEL M, Mihajlovic M, Nedeljkovic M, Pavlovic N, et al
    Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00294.
    PubMed     Abstract available
    
    
    
62. COWAN LT, Buck B, Schwind JS, Lutsey PL, et al
    Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC).
    Int J Cardiol. 2021;325:155-160.
    PubMed     Abstract available
    
    
    
63. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed     Abstract available
    
    
    January 2021
64. HARIHARAN P, Giordano N, Muzikansky A, Kabrhel C, et al
    Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00139.
    PubMed     Abstract available
    
    
    
65. KALARIA SN, Zhu H, Liu Q, Florian J, et al
    Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00106.
    PubMed     Abstract available
    
    
    
66. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    PubMed     Abstract available
    
    
    
67. ZWEIKER D, Manninger M, Sieghartsleitner R, Ebner J, et al
    No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00082.
    PubMed     Abstract available
    
    
    
68. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    PubMed     Abstract available
    
    
    
69. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    PubMed     Abstract available
    
    
    
70. GU K, Mahtta D, Kaneria A, Sharedalal P, et al
    Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR(R) PINNACLE Registry.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34312.
    PubMed     Abstract available
    
    
    
71. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    PubMed     Abstract available
    
    
    December 2020
72. FEMIA G, Zhu D, Choudhary P, Ross SB, et al
    Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34265.
    PubMed     Abstract available
    
    
    
73. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    PubMed     Abstract available
    
    
    
74. CAPIAU A, De Backer T, Grymonprez M, Lahousse L, et al
    Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and EHRA Practical Guide.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34231.
    PubMed     Abstract available
    
    
    November 2020
75. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    PubMed     Abstract available
    
    
    
76. CASU G, D'Angelo G, Ugo F, Ronco F, et al
    Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
    Int J Cardiol. 2020 Nov 24. pii: S0167-5273(20)34168.
    PubMed     Abstract available
    
    
    
77. DOMINGUEZ-ERQUICIA P, Raposeiras-Roubin S, Abbu-Assi E, Cespon-Fernandez M, et al
    Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation.
    Int J Cardiol. 2020 Nov 18. pii: S0167-5273(20)34146.
    PubMed     Abstract available
    
    
    
78. MARKS D, Ho R, Then R, Weinstock JL, et al
    Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.
    Int J Cardiol. 2020 Nov 10. pii: S0167-5273(20)34140.
    PubMed     Abstract available
    
    
    
79. ANDERSSON T, Aspberg S
    Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.
    Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34068.
    PubMed     Abstract available
    
    
    October 2020
80. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    PubMed    
    
    
    
81. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    PubMed     Abstract available
    
    
    
82. FENDER AC, Dobrev D
    The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation.
    Int J Cardiol. 2020 Oct 1. pii: S0167-5273(20)33897.
    PubMed    
    
    
    September 2020
83. PACHOLCZAK-MADEJ R, Bazan-Socha S, Zareba L, Undas A, et al
    Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
    Int J Cardiol. 2020 Sep 12. pii: S0167-5273(20)33818.
    PubMed     Abstract available
    
    
    
84. JOLOBE OMP
    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
    PubMed    
    
    
    August 2020
85. CHANTRARAT T, Krittayaphong R
    Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry.
    Int J Cardiol. 2020 Aug 20. pii: S0167-5273(20)33651.
    PubMed     Abstract available
    
    
    
86. LIU J, Wang Y, Guo W, Cheng Y, et al
    Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33573.
    PubMed     Abstract available
    
    
    
87. VALLABHAJOSYULA S, Verghese D, Subramaniam AV, Kumar V, et al
    Management and outcomes of uncomplicated ST-segment elevation myocardial infarction patients transferred after fibrinolytic therapy.
    Int J Cardiol. 2020 Aug 15. pii: S0167-5273(20)33539.
    PubMed     Abstract available
    
    
    
88. CHANG KW, Xian Y, Zhao X, Mi X, et al
    Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
    Int J Cardiol. 2020 Aug 14. pii: S0167-5273(20)33538.
    PubMed     Abstract available
    
    
    
89. RUTLAND J, Ayoub K, Etaee F, Ogunbayo G, et al
    CHA2DS2-VASc and readmission with new-onset atrial fibrillation, atrial flutter, or acute cerebrovascular accident.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33554.
    PubMed     Abstract available
    
    
    
90. MALAVASI VL, Zoccali C, Brandi MC, Micali G, et al
    Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study.
    Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33555.
    PubMed     Abstract available
    
    
    
91. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
    Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
    Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
    PubMed     Abstract available
    
    
    July 2020
92. LOPES RD, Berger SE, Di Fusco M, Kang A, et al
    A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation.
    Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33439.
    PubMed     Abstract available
    
    
    June 2020
93. HUANG J, Wu N, Xiang Y, Wu L, et al
    Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation.
    Int J Cardiol. 2020 Jun 27. pii: S0167-5273(20)33408.
    PubMed     Abstract available
    
    
    
94. AKHTAR T, Fratti JDC, Mattumpuram J, Fugar S, et al
    Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
    Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33410.
    PubMed     Abstract available
    
    
    
95. PATTI G, Pecen L, Manu MC, Huber K, et al
    Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies.
    Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33388.
    PubMed     Abstract available
    
    
    
96. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
    Response to "Electrocardiographic sexual differences in patients with atrial fibrillation".
    Int J Cardiol. 2020;308:50-51.
    PubMed    
    
    
    May 2020
97. LEIVO J, Anttonen E, Jolly SS, Dzavik V, et al
    The high-risk ECG pattern of ST-elevation myocardial infarction: A substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial).
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)31075.
    PubMed     Abstract available
    
    
    
98. JAUME FP, Aleix OS, Nuria RG, Jordi PR, et al
    High incidence of subclinical atrial fibrillation in patients with syncope monitored with implantable cardiac monitor.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)32451.
    PubMed     Abstract available
    
    
    April 2020
99. PUGLIESE NR, Masi S
    Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
    Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
    PubMed    
    
    
    
100. GEARY L, Hasselstrom J, Carlsson AC, Schenck-Gustafsson K, et al
     An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care.
     Int J Cardiol. 2020 Apr 12. pii: S0167-5273(20)30628.
     PubMed    
     
     
     March 2020
101. YUAN S, Lin A, He QQ, Burgess S, et al
     Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
     Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
     PubMed     Abstract available
     
     
     
102. CHEN L, He W, Liu F, Wang T, et al
     Stroke in pulmonary hypertension: Is it predictable or preventable?
     Int J Cardiol. 2020;303:79.
     PubMed    
     
     
     
103. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
     Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
     Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
     PubMed     Abstract available
     
     
     February 2020
104. NEDIOS S, Dobrev D
     Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification?
     Int J Cardiol. 2020 Feb 19. pii: S0167-5273(20)30218.
     PubMed    
     
     
     January 2020
105. BAE JH, Corban MT, Seo YH, Kim T, et al
     Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
     Int J Cardiol. 2020;299:26-30.
     PubMed     Abstract available
     
     
     
106. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
     Sex-related electrocardiographic differences in patients with different types of atrial fibrillation: Results from the SWISS-AF study.
     Int J Cardiol. 2020 Jan 3. pii: S0167-5273(19)34685.
     PubMed     Abstract available
     
     
     
107. MICHOU E, Gualandro D, Mueller C
     It is B-type and not brain natriuretic peptide after all.
     Int J Cardiol. 2020;298:114-115.
     PubMed    
     
     
     
108. RODRIGUEZ-CASTRO E, Hervella P, Lopez-Dequidt I, Arias-Rivas S, et al
     NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
     Int J Cardiol. 2020;298:93-97.
     PubMed     Abstract available
     
     
     December 2019
109. BAHIT MC, Granger CB, Alexander JH, Mulder H, et al
     Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
     Int J Cardiol. 2019 Dec 30. pii: S0167-5273(19)34634.
     PubMed     Abstract available
     
     
     
110. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
     Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
     Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
     PubMed     Abstract available
     
     
     
111. HU QW, Bao TZ, Yang HR
     NT-pro-BNP: A promising predictor of stroke risk after transient ischemic attack.
     Int J Cardiol. 2019;297:142.
     PubMed    
     
     
     
112. SHAH TG, Sutaria JM, Vyas MV
     The association between pulmonary hypertension and stroke: a systematic review and meta-analysis.
     Int J Cardiol. 2019 Dec 12. pii: S0167-5273(19)35735.
     PubMed    
     
     
     November 2019
113. SPOSATO LA, Spence JD
     Patent foramen ovale in patients with atrial fibrillation.
     Int J Cardiol. 2019 Nov 22. pii: S0167-5273(19)35608.
     PubMed    
     
     
     
114. NAGAI M, Dote K, Kato M
     Left atrial fibrosis after ischemic stroke: How the insular cortex-ganglionated plexi axis interacts?
     Int J Cardiol. 2019;294:16.
     PubMed    
     
     
     
115. JAREMEK VM, Whitehead S, Sposato LA
     Lateralization of the control of cardiovascular autonomic function and left atrial injury after selective right and left insular stroke.
     Int J Cardiol. 2019;294:15.
     PubMed    
     
     
     October 2019
116. LUCIJANIC M, Jurin I, Jurin H, Lucijanic T, et al
     Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
     Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)34260.
     PubMed     Abstract available
     
     
     
117. LI HL, Wu S, Chan YC, Cheng SW, et al
     Early and mid-term mortality and morbidity of contemporary international endovascular treatment for type B aortic dissection - A systematic review and meta-analysis.
     Int J Cardiol. 2019 Oct 24. pii: S0167-5273(19)31112.
     PubMed     Abstract available
     
     
     July 2019
118. SHAH TG, Sutaria JM, Vyas MV
     The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.
     Int J Cardiol. 2019 Jul 31. pii: S0167-5273(19)31075.
     PubMed     Abstract available
     
     
     
119. BORIANI G, Healey JS, Schnabel RB, Lopes RD, et al
     Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
     Int J Cardiol. 2019 Jul 11. pii: S0167-5273(19)32817.
     PubMed     Abstract available
     
     
     May 2019
120. BOTTO GL, Brasca FMA
     Stroke risk assessment in atrial fibrillation: Beyond atrial rhythm.
     Int J Cardiol. 2019 May 24. pii: S0167-5273(19)32435.
     PubMed    
     
     
     
121. STEPIEN K, Nowak K, Wypasek E, Zalewski J, et al
     High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke.
     Int J Cardiol. 2019 May 18. pii: S0167-5273(19)30879.
     PubMed     Abstract available
     
     
     December 2018
122. LEONARD JR, Henry M, Rahouma M, Khan FM, et al
     Systematic preoperative CT scan is associated with reduced risk of stroke in minimally invasive mitral valve surgery: A meta-analysis.
     Int J Cardiol. 2018 Dec 12. pii: S0167-5273(18)35962.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: